Delivery Order SPE2DR25D3501-SPE2DR26FL9JB
- Not listed
- The Defense Logistics Agency awarded a $6,060.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials (5 ml quantity) on November 18, 2025, with completion expected by November 19, 2025. This delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.52 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with an ultimate completion date of December 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under a larger...
- The Defense Logistics Agency awarded a $1,117.74 delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials (5 ml quantity) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded transaction under the company's existing contract vehicles with DLA. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $3,457.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was made on September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.53 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dexamethasone 4 mg/mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,778.44 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on December 11, 2025, with completion expected by December 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,945.52 for Dexamethasone 20 mg/5 mL vials (5 mL quantity) on a firm fixed price basis. This award, issued on July 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for U.S. military...
- The Defense Logistics Agency has awarded a $1,475.48 delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials (5 ml quantity) under a firm fixed price contract type. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and is not designated as a set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Dexamethasone 20 mg/5 mL vials (5 mL unit size) under a firm fixed-price contract valued at $1,069.60. The award was competitively issued on May 30, 2025, with an ultimate completion date of June 2, 2025, and does not include a set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,466.91 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dexamethasone 20 mg/5 mL vials. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9JBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds a significant prime indefinite delivery contract (SPE2DX) valued at $999,999,999.00 through December 2026 that provides comprehensive pharmaceutical support globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for Dexamethasone, a corticosteroid medication commonly used in military healthcare, reflects the company's ongoing role as a key supplier within the DLA's medical supply chain infrastructure supporting Defense Health Agency operations and other government healthcare systems.